Drug recall · June 1, 2022
Losartan Pot/HCTZ 100/12.5 mg 90 Tabs recall
Why: CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits .
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Losartan Pot/HCTZ 100/12.5 mg 90 Tabs NDC 72189-290-90 Packaged and Distributed By: Direct Rx Dawsonville, GA 30534 Mfg. For Macleods Pharma USA, Inc. Plainsboro, NJ 08540
- Lots / codes
Lot: 25OC2116 Exp. 5/31/23
- Quantity
- 11 bottles
- Company
- Direct Rx, Dawsonville, GA
- Distribution
- FL
- Initiated
- May 11, 2022 · Voluntary: Firm initiated
- Classified
- May 24, 2022
- Reported
- June 1, 2022
- Ended
- December 2, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Hydrochlorothiazide / losartan
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.